Cytokinetics clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   FOREST-HCM · Aficamten · HCM

   Primary and study completion pushed from Mar 2028 to Mar 2029

   Also in this update: Primary endpoint(s) modified; Trial sites expanded: 129 → 141 locations

   Cytokinetics·Phase 2/3· NCT04848506· Registry history of NCT04848506 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.